Funder: Food and Drug Administration

Due Dates: July 25, 2025 (Application) | December 26, 2025 (Letter of Intent) | January 30, 2026 (Application) | June 19, 2026 (Letter of Intent) | July 24, 2026 (Application) | December 25, 2026 (Letter of Intent) | January 29, 2027 (Application)

Funding Amounts: Up to $250,000 total costs per year; maximum 1 year for most studies, up to 3 years for long-term toxicological studies.

Summary: Supports research to develop or advance FDA-designated new animal drugs for minor uses in major species or for minor species, requiring INAD, MUMS designation, and FDA protocol concurrence.

Key Information: Protocol must be FDA-reviewed and concurred before application; late applications are not accepted.